KEYNOTE-585

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

KEYNOTE-585

Dec 29, 2023, 16:34 | Insight

Erman Akkus: KEYNOTE-585 - although pathological complete response improved, no survival advantage

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "KEYNOTE-585: Neoadjuvant and adjuvant…

All: 1 Posts: 1 - 100

'

Cyril Konto: I Trademarked The Word ‘Multispecific’ The Day I Arrived

'

Levi Garraway: Transforming Oncology Through Precision, Resilience And Heart

'

20 Posts Not to Miss from ASCO 2025

'

Jessie J Diagnosed with Early-Stage Breast Cancer: What Is the Prognosis?

'

Robin Zon: The Official End of My Term as ASCO President

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023